Before the Bedside Manner

Health care licensing regulators grapple with innovation, safety, and expertise when credentialing providers.

Will FDA Guidance Hasten Testing for COVID-19?

In the face of a massive viral outbreak, a federal regulator issues unprecedented guidance on validating coronavirus testing.

The Regulatory Race Against a Public Health Crisis

The federal government responds to the coronavirus pandemic by amending its foreign quarantine rules.

Can the U.S. Outpace Disease Outbreaks?

In the United States, disease outbreaks challenge emergency preparedness.

Resolving Regulatory Confusion Over Medical Software

FDA clarifies enforcement priorities for medical device clinical decision support software.

The Health-Sharing Duck

Health care sharing ministries seem similar to traditional health insurance, but they evade the scrutiny of federal and state regulators.

State-Level Marijuana Regulation

As states legalize marijuana, regulators must determine how to oversee its use.

Increasing Organ Donation in the United States

Two proposed rules aim to improve the rate of organ donations in the United States.

FDA Announces Age Change for Tobacco Sales

Online announcement declares that new tobacco age restrictions are effective immediately.

Drug Approval During a Public Health Crisis

FDA’s approval of an Ebola vaccine can serve as a framework for drug development during other epidemics.

Proposed Rule Seeks to Promote Value-Based Health Care

Federal regulators seek to expand safe harbors for provider care coordination arrangements.


Regulating Mobile Medical Applications

As mobile medical applications continue to proliferate, regulators lack a solid framework for oversight.